The primary role of Fevadol Extra is to provide symptomatic relief across domains where additional support is needed for managing pain and fever. This combination is commonly used to help with acute or disruptive symptom patterns, including headache, acute migraine episodes, backache, muscular aches, and fever associated with colds and influenza.

The medication is relevant in contexts marked by increased discomfort to address symptoms related to both physical discomfort and systemic imbalance. For patients, the formulation helps ease the overall symptom burden during these difficult episodes, which contributes to improved comfort during symptomatic periods.

“The combination may assist with maintaining comfort by providing supportive relief when symptoms interfere with routine activities.”

Quick Fact: Relief for Acute Discomfort

Quick Fact: Relief for Acute Discomfort The combination is applied in scenarios where short-term symptomatic assistance is needed for mild to moderate acute pain and the simultaneous moderation of elevated body temperature, helping to sustain comfort during temporary physiological imbalance.

The eligibility profile for Fevadol Extra is defined by absolute prohibitions and specific restrictions based on age, organ function, and physiological states, as documented in regulatory labels.

Eligibility Status	Population Groups Defined in Regulatory Label
Contraindicated	Patients with known hypersensitivity to paracetamol or caffeine. Individuals using any other paracetamol-containing product.
Not Recommended	Children under 12 years of age. Individuals who are pregnant or breastfeeding.

Age and Condition-Based Restrictions The medicine is approved for Adults and Adolescents aged 12 years and over. Regulatory documents advise that caution is necessary for patients with hepatic (liver) or renal (kidney) impairment. The hazard of overdose is greater in those with non-cirrhotic alcoholic liver disease or conditions causing glutathione depletion. Due to the caffeine component, use is generally not recommended during pregnancy or breastfeeding.

The regulatory documentation for Fevadol Extra structures its interaction profile around its two active components, Acetaminophen (Paracetamol) and Caffeine.

Interaction-Related Restrictions

The most significant regulatory restriction is the prohibition of co-administration with any other medicine containing Acetaminophen. This is strictly enforced to prevent exceeding the total daily dose and associated risk of severe liver damage. Co-administration with Alcohol is formally cited as increasing the risk of severe hepatotoxicity, particularly with a chronic intake of three or more drinks per day.

Documented Pharmacokinetic Patterns

Interactions involving the metabolic clearance of the medicine are officially noted. Enzyme-inducing medicines (such as Carbamazepine and Phenytoin) may reduce Acetaminophen plasma concentrations. Conversely, other agents may inhibit the metabolic pathways (like CYP1A2 for Caffeine), which can increase the systemic exposure of the active components.

Exposure Modification and Timing Rules

A significant exposure-modifying interaction exists with Warfarin and other oral anticoagulants. Prolonged, regular use of the Acetaminophen component is documented to enhance the anticoagulant effect, requiring caution due to the risk of an elevated International Normalized Ratio (INR).

Furthermore, the official profile outlines timing-based separation requirements for certain substances, such as Cholestyramine, to avoid reduced absorption, and specific restrictions concerning the co-administration of Busulfan.

This risk is formally designated as greater in populations with severe hepatic impairment.

Central Modulation of Nociception and Thermoregulation

The primary component, Acetaminophen, exerts its effect by acting in the central nervous system (CNS), not by robustly blocking inflammation in peripheral tissues. Its mechanism involves the weak inhibition of specific Cyclooxygenase (COX) enzymes within the CNS, which limits the synthesis of Prostaglandin E2 ( PGE2). By reducing PGE2 levels, the drug modulates the hypothalamic heat-regulating center, triggering mechanisms of heat dissipation, and acts to increase the central pain threshold in the brain.

---

Adenosine Antagonism and Mechanistic Potentiation

The Caffeine component influences the CNS by acting as a non-selective competitive antagonist at Adenosine Receptors. Since adenosine is an inhibitory neuromodulator, blocking its receptors leads to increased central neuronal excitability and promotes the release of neurotransmitters. Mechanistically, this action potentiates the central effects of Acetaminophen, contributing to a potentiated effect on central nociception and affecting CNS arousal by adjusting overall signaling activity.

---

Specificity and Limitations of Mechanism

The drug's mechanism is largely CNS-dependent, meaning it has limited capacity to modulate pain driven predominantly by peripheral inflammation, as its action is easily overcome by local factors at the site of tissue damage. The mechanism is primarily restricted to central physiological modulation and does not encompass significant peripheral anti-inflammatory action.

Fevadol Extra is administered via the oral route using its film-coated tablet formulation. The standard regimen for adults and adolescents aged 16 years and over involves a single dose of two tablets (1000 mg Acetaminophen and 130 mg Caffeine). The dose may be repeated, but the standard instruction mandates a minimum interval of four hours between doses. Under no circumstances should more than eight tablets (4000 mg Acetaminophen and 520 mg Caffeine) be taken within any 24-hour period.

The medicine is designated for short-term use. Guidelines stipulate a limit for continuous, unsupervised administration: typically no more than 5 days for pain relief and 3 days for fever. Prolonged daily use of this combination product requires oversight by a healthcare professional.

Dosing guidelines are modified for younger populations. Adolescents aged 12 to 15 years should take a single dose of one tablet and must not exceed a total of four tablets in 24 hours. The medicine is not recommended for use in children under 12 years of age.

A crucial procedural condition is that the tablets must be swallowed whole with water. Furthermore, proper use requires strict avoidance of all other medications containing Acetaminophen (Paracetamol) to prevent exceeding the maximum safe daily threshold established for safety. When calculating total daily intake, the caffeine content of the medicine must also be accounted for across all sources.

Evidence for the Acute Management of General Pain

Research examined this medicine in studies focusing on outcomes related to physical discomfort during conditions characterized by episodic or acute changes. The evidence foundation relies primarily on short-term, single-dose Randomized Controlled Trials (RCTs) and systematic reviews, which aggregate results from these studies. The studies explored outcomes related to the intensity of discomfort, the speed of symptom change observed, and patient-reported outcomes describing perceived discomfort. Findings describe patterns observed when the combination was compared against placebo and single-ingredient formulations, particularly in models like post-operative pain.

What remains uncertain is information related to the long-term application of this combination, as follow-up durations were limited to a single administration. The research structure is built around immediate, acute symptoms; therefore, there is limited information for long-term outcomes, and data for chronic pain management are insufficient.

---

Evidence for Acute Headache and Migraine Episodes

Research also evaluated this medicine in studies exploring how symptoms change over time for conditions associated with acute or disruptive episodes, such as episodic tension-type headache and acute migraine attacks. Study designs included randomized, placebo-controlled trials. Studies explored outcomes related to severe symptoms, measuring metrics such as the proportion of participants achieving a specified symptom level (e.g., pain-free state) or a specified reduction in symptom intensity, typically assessed at the 2-hour mark.

---

Research on the Combination Strategy (Acetaminophen Plus Caffeine)

Research explored the combination's profile based on the rationale for combining a non-opioid pain reliever with caffeine. Studies examined the strategic use of the combination by comparing the fixed-dose product against the active pain reliever component used alone. Findings describe patterns observed in studies designed to examine the intended role of the second ingredient on outcomes related to physical discomfort.

---

Evidence Gaps and Areas for Further Study

A key research limitation is that studies focus on acute, episodic symptom patterns; evidence exploring long-term symptom management is not available. Furthermore, evidence is limited for certain groups. While the general adult population was observed, data for certain subgroups (such as older adults or those with significant coexisting health conditions) remain insufficient, and subgroup findings are uncertain.

Key Studies & References Acetaminophen and Caffeine Oral: Drug Information (MedlinePlus/NIH)

Common questions about Fevadol Extra (FAQ)

---

Q: Can Fevadol Extra be taken on an empty stomach?

Official instructions indicate the medicine is meant to be swallowed whole with water. Taking the medicine with food may slow down the rate at which the Acetaminophen component is absorbed into the body. This phenomenon is a pharmacokinetic property noted in official product information.

---

Q: How quickly does Fevadol Extra start to work?

Studies and official information indicate that the combination product has been observed to begin providing relief from pain or fever within one to two hours following administration in some individuals. This information is based on clinical trial data examining the speed of the medicine’s effect.

---

Q: How long does the effect of Fevadol Extra last?

The dosing instructions provided in official regulatory documents mandate a minimum interval of four hours between doses. The four-hour dosing interval reflects the period of time for which relief is generally anticipated before the next dose may be considered.

---

Q: Is Fevadol Extra considered a strong pain reliever?

Fevadol Extra is classified as a non-opioid analgesic combination. It is generally indicated for the temporary relief of mild to moderate aches and pain, according to the medicine's official therapeutic indications.

---

Q: Can Fevadol Extra cause drowsiness?

The side effects linked to the caffeine component, such as nervousness, restlessness, and insomnia, are central nervous system (CNS) stimulant effects. Drowsiness is therefore not typically listed as a known or common side effect in the official product information.

---

Q: Is it common to feel jittery after taking Fevadol Extra?

Effects such as nervousness, restlessness, agitation, and tremors have been reported, linked to the caffeine component. Official documentation notes that the frequency of these effects is often classified as 'Not Known,' meaning it cannot be reliably estimated from available data.

---

Q: Can people with high blood pressure use Fevadol Extra?

Regulatory documents caution that patients with pre-existing conditions, including severe or uncontrolled hypertension (high blood pressure), may require professional review before use due to the known stimulant effects of caffeine.

---

Q: Is Fevadol Extra safe for older adults?

While the medicine is approved for the general adult population, regulatory documents and research evidence note that data for certain subgroups, such as older adults, are insufficient. Use in this population may necessitate individualized review or professional monitoring, as data is noted as being insufficient.

---

Q: What are the most common side effects listed for Fevadol Extra?

Official labels classify side effects by their expected frequency. The available regulatory text for this medicine details effects categorized as 'Very Rare' (e.g., severe skin disorders) and 'Not Known' (e.g., nervousness, insomnia), but does not specifically list side effects designated as 'Common.'

---

Q: Do any foods or drinks interact with Fevadol Extra?

Yes. Official documents strictly prohibit co-administration with alcohol due to the increased risk of severe liver damage. Official guidance also recommends limiting caffeine intake from other sources like coffee, tea, and soft drinks to avoid excessive stimulation.

---

Q: Can Fevadol Extra be taken at night for sleep?

Due to the caffeine component, potential side effects noted in regulatory documents include insomnia and restlessness. The medicine is not intended or recommended for use as a sleep aid.

---

Q: What organs does Fevadol Extra affect?

The medicine’s primary therapeutic effect acts on the Central Nervous System (CNS) to relieve pain and fever. Regulatory documents caution that due to the Acetaminophen component, the Liver (hepatic) and Kidneys (renal) can be affected, particularly in cases of overdose or pre-existing conditions.

---

Q: Can Fevadol Extra interact with herbal supplements?

Regulatory warnings regarding Acetaminophen interactions specifically include enzyme-inducing medicines and the herbal supplement St John's Wort. Official information suggests patients discuss all concurrent supplements with a healthcare professional to identify potential interactions.

---

Q: Does Fevadol Extra affect blood sugar levels?

Regulatory documentation regarding overdose management notes that abnormalities of glucose metabolism and metabolic acidosis may occur in severe cases. There is no official warning cited for blood sugar effects during routine, recommended use.

---

Q: How is Fevadol Extra different from NSAID medicines?

The active ingredient Acetaminophen works primarily in the Central Nervous System (CNS) to raise the pain threshold. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) work differently, mainly by reducing inflammation in the body’s peripheral tissues. This medicine has limited peripheral anti-inflammatory action.

---

Q: Do regulatory bodies approve Fevadol Extra for specific conditions?

The medicine is approved for the temporary relief of mild to moderate pain and for the reduction of fever. It is often specifically indicated for the symptomatic relief of headache and acute migraine attacks, according to regulatory documents.

---

Q: What if I experience unusual side effects while taking Fevadol Extra?

Official patient information indicates that if severe symptoms are experienced, such as signs of a serious allergic reaction (e.g., severe skin rash or difficulty breathing), the medicine should be discontinued and immediate medical attention sought. All side effects should be reported to a healthcare professional.

---

Q: Does Fevadol Extra cause stomach irritation?

The Acetaminophen component is not typically associated with gastric irritation in the way NSAIDs are. However, stomach pain is an effect noted in regulatory documents, particularly in cases of overdose or in certain co-formulations.

---

Q: Are there known withdrawal symptoms from Fevadol Extra?

While the combination is not associated with typical substance withdrawal, official guidance cautions that frequent or prolonged use of any pain reliever can potentially lead to medication-overuse (rebound) headaches upon cessation.

---

Q: Does Fevadol Extra have a risk of rebound headaches?

Regulatory guidance indicates that taking any type of pain reliever for headaches too frequently or for too long may lead to medication-overuse, commonly known as 'rebound' headaches.

---

Q: Does taking Fevadol Extra with food change how it works?

Official pharmacokinetic properties indicate that taking the medicine with food may slow down the rate at which the Acetaminophen component is absorbed into the body. This change in absorption rate may affect the time it takes for the medicine to begin working.

Storage and Disposal Requirements

Fevadol Extra must be stored in specific conditions as defined in regulatory labeling to maintain its stability and prevent public safety risks.

Storage Conditions

Condition	Requirement
Temperature	Store below 25 C or between 20 C to 25 C (68 F to 77 F).
Environmental	Must be protected from excessive heat (above 40 C), light, and moisture.
Safety	Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired medicine must be disposed of in accordance with local requirements. The official recommendation is to utilize a local drug take-back program or mail-back envelope. It is prohibited to dispose of this medicine by flushing it down a toilet or sink. If a take-back program is unavailable, the medicine should be mixed with an undesirable substance (e.g., dirt) and placed in a sealed container before discarding it in the household trash.